Table of Contents 2
List of Tables 7
List of Figures 7
Kyowa Hakko Kirin Co., Ltd. Spshot 8
Kyowa Hakko Kirin Co., Ltd. Overview 8
Key Information 8
Key Facts 8
Kyowa Hakko Kirin Co., Ltd. - Research and Development Overview 9
Key Therapeutic Areas 9
Kyowa Hakko Kirin Co., Ltd. - Pipeline Review 13
Pipeline Products by Stage of Development 13
Pipeline Products - Monotherapy 14
Pipeline Products - Partnered Products 15
Partnered Products/Combition Treatment Modalities 16
Pipeline Products - Out-Licensed Products 17
Out-Licensed Products/Combition Treatment Modalities 18
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products Glance 19
Kyowa Hakko Kirin Co., Ltd. - Late Stage Pipeline Products 19
Pre-Registration Products/Combition Treatment Modalities 19
Phase III Products/Combition Treatment Modalities 20
Kyowa Hakko Kirin Co., Ltd. - Clinical Stage Pipeline Products 21
Phase II Products/Combition Treatment Modalities 21
Phase I Products/Combition Treatment Modalities 22
Kyowa Hakko Kirin Co., Ltd. - Early Stage Pipeline Products 23
Preclinical Products/Combition Treatment Modalities 23
Discovery Products/Combition Treatment Modalities 24
Kyowa Hakko Kirin Co., Ltd. - Drug Profiles 25
brodalumab 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
darbepoetin alfa 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
granisetron ER 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
romiplostim 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
tivozanib hydrochloride 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
benralizumab 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
burosumab 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
istradefylline 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
mogamulizumab 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
MT-4580 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
tivantinib 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
bardoxolone methyl 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
bleselumab 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
KHK-4083 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
BIW-8962 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
antithrombin III (human) 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
entinostat 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
KHK-2823 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
KHK-2898 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
KHK-6640 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
CHKM-4927 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
K-685 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
K-756 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
KHK-KRAS 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
KHK-XXX 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
KM-2812 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
Pr-1E11 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
Small Molecules to Inhibit ASK1 for Amyotropic Lateral Sclerosis 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
Small Molecules to Inhibit Mitotic Kinesin Eg5 for Ovarian Cancer 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
Z-3G1 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
K-777 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
Small Molecules Targeting Protein-Protein Interactions for Undisclosed Indication 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
Kyowa Hakko Kirin Co., Ltd. - Pipeline Alysis 76
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Target 76
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Route of Administration 78
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Molecule Type 79
Kyowa Hakko Kirin Co., Ltd. - Pipeline Products by Mechanism of Action 80
Kyowa Hakko Kirin Co., Ltd. - Recent Pipeline Updates 82
Kyowa Hakko Kirin Co., Ltd. - Dormant Projects 115
Kyowa Hakko Kirin Co., Ltd. - Discontinued Pipeline Products 116
Discontinued Pipeline Product Profiles 116
AGS-004 116
darbepoetin alfa 116
KHK-2866 117
KHK-6188 117
KRN-330 117
KRX-0601 117
KW-2449 117
KW-2450 117
KW-2478 118
KW-7158 118
litronesib 118
mogamulizumab 118
pibrozelesin hydrobromide 118
rocapuldencel-t 118
SAR-252067 119
tivantinib 119
tivozanib hydrochloride 119
Kyowa Hakko Kirin Co., Ltd. - Company Statement 120
Kyowa Hakko Kirin Co., Ltd. - Locations And Subsidiaries 121
Head Office 121
Other Locations & Subsidiaries 121
Appendix 124
Methodology 124
Coverage 124
Secondary Research 124
Primary Research 124
Expert Panel Validation 124
Contact Us 124
Disclaimer 125